Does familial non-medullary thyroid cancer adversely affect survival?

Triponez, Frédéric; Wong, Mariwil; Sturgeon, Cord; Caron, Nadine; Ginzinger, David G; Segal, Mark R; Kebebew, Electron; Duh, Quan-Yang; Clark, Orlo H

doi:10.1007/s00268-005-0398-x

Scientific article

English

Does familial non-medullary thyroid cancer adversely affect survival?

ContributorsTriponez, Frédéric; Wong, Mariwil; Sturgeon, Cord; Caron, Nadine; Ginzinger, David G; Segal, Mark R; Kebebew, Electron; Duh, Quan-Yang; Clark, Orlo H

Published inWorld journal of surgery, vol. 30, no. 5, p. 787-793

Collection

Open Access - Licence nationale Springer

Publication date2006

Abstract

Familial non-medullary thyroid cancer (FNMTC) is associated with a higher rate of multifocality and a higher recurrence rate than sporadic thyroid cancer. However, the effect of FNMTC on life expectancy is unknown.

Keywords

Adenocarcinoma, Follicular/mortality/pathology
Adenocarcinoma, Papillary/mortality/pathology
Adenoma, Oxyphilic/mortality/pathology
Adult
Genetic Diseases, Inborn
Humans
Life Expectancy
Middle Aged
Retrospective Studies
Survival Analysis
Thyroid Neoplasms/mortality/pathology

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Cancer du poumon et mésothéliome pleural malin (944)

Citation (ISO format)

TRIPONEZ, Frédéric et al. Does familial non-medullary thyroid cancer adversely affect survival? In: World journal of surgery, 2006, vol. 30, n° 5, p. 787–793. doi: 10.1007/s00268-005-0398-x

Article (Published version)

Identifiers

PID : unige:38904
DOI : 10.1007/s00268-005-0398-x
PMID : 16479341

Journal ISSN0364-2313

734views

328downloads

Creation24/07/2014 16:11:00

First validation24/07/2014 16:11:00

Update time14/03/2023 21:28:15

Status update14/03/2023 21:28:15

Last indexation30/10/2024 19:31:38

Archive ouverte UNIGE

Does familial non-medullary thyroid cancer adversely affect survival?

Familial non-medullary thyroid cancer (FNMTC) is associated with a higher rate of multifocality and a higher recurrence rate than sporadic thyroid cancer. However, the effect of FNMTC on life expectancy is unknown.

Technical informations